Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Anderson

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Medicine|April 3, 2018
An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohortPinkal Desai, Robert Wallace, Matthew L Anderson, et al.
JAMA Internal Medicine|June 6, 2025
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical TrialJane R Montealegre, Susan G Hilsenbeck, Shaun Bulsara, et al.
Trials|October 22, 2020
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trialJane R Montealegre, Matthew L Anderson, Susan G Hilsenbeck, et al.
American Journal of Preventive Medicine|November 7, 2023
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health SystemSusan L Parker, Trisha L Amboree, Shaun Bulsara, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2012
Dual targeting of mTOR and aurora-A kinase for the treatment of uterine LeiomyosarcomaKari J Brewer Savannah, Elizabeth G Demicco, Kristelle Lusby, et al.
Cancer Research|February 22, 2012
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signalingPingyu Zhang, Katelynn Bill, Juehui Liu, et al.
American Journal of Obstetrics and Gynecology|February 18, 2011
Prospective evaluation of insulin resistance among endometrial cancer patientsJennifer K Burzawa, Kathleen M Schmeler, Pamela T Soliman, et al.
Plos One|March 13, 2010
Discovery of novel microRNAs in female reproductive tract using next generation sequencingChad J Creighton, Ashley L Benham, Huifeng Zhu, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Medicine|April 3, 2018
An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohortPinkal Desai, Robert Wallace, Matthew L Anderson, et al.
JAMA Internal Medicine|June 6, 2025
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical TrialJane R Montealegre, Susan G Hilsenbeck, Shaun Bulsara, et al.
Trials|October 22, 2020
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trialJane R Montealegre, Matthew L Anderson, Susan G Hilsenbeck, et al.
American Journal of Preventive Medicine|November 7, 2023
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health SystemSusan L Parker, Trisha L Amboree, Shaun Bulsara, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2012
Dual targeting of mTOR and aurora-A kinase for the treatment of uterine LeiomyosarcomaKari J Brewer Savannah, Elizabeth G Demicco, Kristelle Lusby, et al.
Cancer Research|February 22, 2012
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signalingPingyu Zhang, Katelynn Bill, Juehui Liu, et al.
American Journal of Obstetrics and Gynecology|February 18, 2011
Prospective evaluation of insulin resistance among endometrial cancer patientsJennifer K Burzawa, Kathleen M Schmeler, Pamela T Soliman, et al.
Plos One|March 13, 2010
Discovery of novel microRNAs in female reproductive tract using next generation sequencingChad J Creighton, Ashley L Benham, Huifeng Zhu, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
Pageof 9